Potent inhibition of human telomerase by helenalin

Pei-Rong Huang1, Yuan-Ming Yeh, Tzu-Chien V Wang

  • 1Department of Molecular and Cellular Biology, Chang Gung University, Kwei-San, Tao-Yuan 333, Taiwan, ROC.

Cancer Letters
|August 23, 2005
PubMed

Insights

Helenalin, a natural compound, effectively inhibits human telomerase, a key target in cancer therapy. This selective inhibition of telomerase and hTERT expression in cancer cells contributes to helenalin's anti-tumor activity.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Telomerase is active in most cancers but repressed in normal cells, making it a significant cancer therapy target.
  • Inhibiting telomerase has shown potential in limiting cancer cell growth in vitro.
  • Helenalin is a natural sesquiterpene lactone with potential therapeutic applications.

Purpose of the Study:

  • To investigate helenalin as a potent and selective inhibitor of human telomerase.
  • To elucidate the mechanism of helenalin's action on telomerase.
  • To determine the role of telomerase inhibition in helenalin's anti-tumor effects.

Main Methods:

  • In vitro studies to assess telomerase inhibition by helenalin.
  • Time- and concentration-dependent inactivation assays.
  • Selectivity tests against other enzymes and protein effects.
  • Analysis of hTERT and telomerase expression in hematopoietic cancer cells.

Main Results:

  • Helenalin directly inactivates human telomerase in a dose- and time-dependent manner.
  • Helenalin exhibits selectivity, with no inhibition of other tested enzymes and resistance to protein interference.
  • Helenalin significantly inhibits hTERT and telomerase expression in hematopoietic cancer cells.

Conclusions:

  • Helenalin is a potent and selective inhibitor of human telomerase.
  • The anti-tumor activity of helenalin is, at least partly, due to its telomerase inhibitory effects.
  • Helenalin represents a promising therapeutic agent targeting telomerase in cancer treatment.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...